Charles River Lbrtrs ntrntl Inc (N:CRL)
Business Focus: Biotechnology & Medical Research
Jun 17, 2024 08:00 am ET
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a plasmid DNA and retrovirus vector production program agreement. As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Captain T Cell will have access to established plasmid and viral vector contract development and manufacturing organization (CDMO) capabilities and advisory services ahead of Captain T Cell’s plan to manufacture a TCR-T cell therapy for solid tumor patients for a Phase I clinical trial.
Jun 13, 2024 08:00 am ET
CHARLES RIVER SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Charles River Laboratories Intl. (NYSE: CRL) and Encourages Long-Term CRL Shareholders to Contact the Firm
Kaskela Law LLC announces that it is investigating Charles River Laboratories Intl. (NYSE: CRL) (“Charles River”) on behalf of the company’s long-term shareholders. Recently a securities fraud complaint was filed against Charles River on...
Jun 12, 2024 03:21 pm ET
CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories’ Directors and Officers for Breach of Fiduciary Duties
Johnson Fistel, LLP (www.johnsonfistel.com), a shareholder rights law firm, announces its continuing investigation of whether certain directors and officers of Charles River Laboratories International, Inc. (NYSE: CRL) breached their fiduciary...
Jun 06, 2024 11:57 am ET
CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories’ Directors and Officers for Breach of Fiduciary Duties
Johnson Fistel, LLP (www.johnsonfistel.com), a shareholder rights law firm, announces its continuing investigation of whether certain directors and officers of Charles River Laboratories International, Inc. (NYSE: CRL) breached their fiduciary...
May 30, 2024 08:00 am ET
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks. Based on decades of viral vector contract development and manufacturing organization (CDMO) experience, the Company has designed a methodical program to drive successful, accelerated process transfer to its Maryland-based viral vector center of excellence (CoE) in as little as nine months.
May 29, 2024 12:18 pm ET
Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by specific officers at NuScale Power Corporation (NYSE: SMR), B. Riley Financial, Inc. (NASDAQ: RILY), Charles River Laboratories International,...
May 22, 2024 12:10 pm ET
Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
Johnson Fistel, LLP is conducting a thorough investigation into possible infractions of federal and state securities laws by specific officers at NuScale Power Corporation (NYSE: SMR), B. Riley Financial, Inc. (NASDAQ: RILY), Charles River...
May 09, 2024 07:00 am ET
Charles River Laboratories Announces First-Quarter 2024 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2024. For the quarter, revenue was $1.01 billion, a decrease of 1.7% from $1.03 billion in the first quarter of 2023.
Apr 23, 2024 05:34 pm ET
CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories’ Directors and Officers for Breach of Fiduciary Duties
Johnson Fistel, LLP (www.johnsonfistel.com), a shareholder rights law firm, announces its continuing investigation of whether certain directors and officers of Charles River Laboratories International, Inc. (NYSE: CRL) breached their fiduciary...
Apr 22, 2024 08:00 am ET
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quarter of 2024, significantly ahead of the original target date. In 2020, Charles River became one of the first 300 members of RE100, a global corporate renewable energy initiative, and comm
Apr 16, 2024 08:00 am ET
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing. The initiative aims to drive the new standard for drug discovery and development and encapsulates the Company’s initial $200 million investment over the past four years and its five-year goal of investing an additional $300 million. This investment spans a portfolio of technology innovations, partnerships, and advocacy efforts to reduce the use of animal testing.
Apr 12, 2024 08:00 am ET
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 9th, at 8:30 a.m. ET.
Apr 11, 2024 08:00 am ET
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI) decision support tool developed in collaboration with Deciphex, an innovator in pathology AI. By combining Deciphex’s unique digital pathology solutions with Charles River’s robust non-clinical pathology programs, clients of both organizations will have access to the technology-driven capabilities to accelerate primary evaluation and peer review in toxicologic pathology assessment, enhancing decision-making in drug discovery and safety asses
Apr 09, 2024 08:00 am ET
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with Axovia Therapeutics Ltd. Charles River will manufacture High Quality (HQ) gene of interest plasmid to support the development of Axovia’s gene therapies for ciliopathies,
Apr 04, 2024 08:00 am ET
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus, a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement. Ship of Theseus will leverage Charles Rive
Apr 04, 2024 08:00 am ET
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus, a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement. Ship of Theseus will leverage Charles Riv
Apr 02, 2024 09:00 pm ET
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL) on behalf of long-term stockholders following a class action...
Apr 01, 2024 08:00 am ET
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that its industry-leading team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting. Charles River will present technology-driven capabilities and
Mar 27, 2024 08:00 am ET
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2023 Corporate Citizenship Report, which includes progress and results from 2022 and 2023. The 2023 report demonstrates Charles River’s priorities and commitments across its strategic En
Mar 21, 2024 08:00 am ET
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading medical education institution with a world-renowned medical research field of stem cell biology and therapy, today announced a High Quality (HQ) plasmid DNA
Mar 14, 2024 08:00 am ET
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
Charles River Laboratories International, Inc. (NYSE: CRL) and Navega Therapeutics, Inc., a biotechnology company developing epigenetic gene therapies, today announced an AAV9 production program agreement. As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Navega will have access to established contract development an
Mar 12, 2024 08:00 am ET
Charles River Laboratories to Present at Barclays Global Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13th, at 10:15 a.m. ET. Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.
Feb 21, 2024 08:00 am ET
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC® (Chemistry, Manufacturing and Controls) platform. This new alliance provides early-stage biotechnology companies a unique solution to rapidly transition from pre-clinical activities to first-in-human clinical trials.
Feb 20, 2024 08:08 am ET
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an agreement with Pluristyx Inc., a leading provider of tools, technologies, and services for the development of cell therapies. The collaboration provides Charles River with broad access to highly characterized and unique stem cell lines, including high-q
Feb 14, 2024 07:00 am ET
Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2023 and provided guidance for 2024. For the quarter, revenue was $1.01 billion, a decrease of 7.9% from $1.10 billion in the fourth quarter of 2022.
Feb 02, 2024 11:18 am ET
Investigation Alert Dollar General, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below
Dollar General Corporation Johnson Fistel, LLP is investigating potential claims on behalf of Dollar General Corporation (NYSE: DG) against certain of its officers and directors. If you are a current, long-term shareholder of Dollar General...
Jan 29, 2024 08:00 am ET
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
Building upon its flagship Endosafe® cartridge technology, Charles River Laboratories International, Inc. (NYSE: CRL) has advanced this innovation one step further and combined it with their recombinant cascade reagent (rCR) to launch the Endosafe® Trillium™ rCR cartridge offering. Expanding its robust bacterial endotoxin testing (BET) portfolio with a new animal-free testing solution, this offering, which builds on Charles River’s existing Trillium rCR vial product, enhances testing efficiency and accelerates manufacturing timelines while simultaneously contributing to C
Jan 24, 2024 04:30 pm ET
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US, to its Board of Directors. Ms. Kemps-Polanco has extensive pharmaceutical industry experience in leading commercial organizations that will provide a wealth of healthcare business leadership knowledge and sales and marketing expertise to Charles River’s Board. As a member of the Board, Ms. Kemps-Polanco will serve on the Compensation and Strategic Planning and Capital Allocation Committees.
Jan 23, 2024 04:30 pm ET
Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2023 financial results and provide 2024 guidance on Wednesday, February 14th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 14th, at 8:30 a.m. ET.
Jan 16, 2024 01:34 pm ET
Investigation Alert Dollar General, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below
Dollar General Corporation Johnson Fistel, LLP is investigating potential claims on behalf of Dollar General Corporation (NYSE: DG) against certain of its officers and directors. If you are a current, long-term shareholder of Dollar General...
Jan 16, 2024 08:00 am ET
Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline adeno-associated virus (AAV)-based gene therapy programs.
Jan 08, 2024 08:00 am ET
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th, at 10:30 a.m. PST (1:30 p.m. EST). Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.
Dec 18, 2023 08:00 am ET
Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
Charles River Laboratories International, Inc. (NYSE: CRL) today announced an important milestone in their strategic collaboration to manufacture CASGEVY™ (exagamglogene autotemcel [exa-cel]). CASGEVY is approved in some countries for certain eligible patients.
Dec 12, 2023 08:00 am ET
Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an agreement with CELLphenomics, a service-based biotechnology company that is using 3D hydrogel technology to advance the understanding of the tumor microenvironment and predict therapeutic efficacy. This enhanced offering will provide Charles River clients with access to
Dec 05, 2023 12:00 pm ET
Investigation Alert Dollar General, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Dollar General Corporation Johnson Fistel, LLP is investigating potential claims on behalf of Dollar General Corporation (NYSE: DG) against certain of its officers and directors. If you are a current, long-term shareholder of Dollar General...
Nov 28, 2023 10:48 am ET
Investigation Alert FedEx, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
FedEx Corporation (NYSE: FDX) Johnson Fistel, LLP is investigating potential claims on behalf of FedEx Corporation (NYSE: FDX) against certain of its officers and directors. If you are a current, long-term shareholder of FedEx holding shares...
Nov 28, 2023 08:00 am ET
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
Charles River Laboratories International, Inc. (NYSE: CRL) and Genetic Cures for Kids Inc (GC4K), an Australian non-profit foundation focused on research programs and clinical trials to find cures for rare diseases, today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration.
Nov 27, 2023 08:30 am ET
Charles River Laboratories to Present at Evercore ISI Investor Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29th, at 9:10 a.m. ET. Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.
Nov 22, 2023 06:39 pm ET
Investigation Alert FedEx, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
FedEx Corporation (NYSE: FDX) Johnson Fistel, LLP is investigating potential claims on behalf of FedEx Corporation (NYSE: FDX) against certain of its officers and directors. If you are a current, long-term shareholder of FedEx holding shares...
Nov 17, 2023 02:47 pm ET
Investigation Alert FedEx, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
FedEx Corporation (NYSE: FDX) Johnson Fistel, LLP is investigating potential claims on behalf of FedEx Corporation (NYSE: FDX) against certain of its officers and directors. If you are a current, long-term shareholder of FedEx holding...
Nov 16, 2023 08:00 am ET
Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its CliniPrime™ suite of Good Manufacturing Practice (GMP)-compliant offerings with the launch of CliniPrime Cryopreserved Leukopaks for cell therapy development and manufacturing. All CliniPrime products meet regulatory guidelines for clinical trial development and commercial manufacturing of advanced therapies.
Nov 13, 2023 09:00 am ET
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Charles River Laboratories International, Inc. (NYSE: CRL) and Aitia, a leader in the application of Causal AI and Digital Twins, today announced a strategic agreement that gives Aitia access to
Nov 13, 2023 08:04 am ET
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology researchCharles River to make an equity investment in Aitia as part of the agreementWILMINGTON, Mass. and SOMERVILLE, Mass., Nov. 13, 2023 /PRNewswire/ -- Charles River Laboratories International, Inc. (NYSE: CRL) and Aitia, a leader in the application of Causal AI and Digital Twins, today announced a strategic agreement that gives Aitia access to Logica™, Charles River's Artificial Intelligence (AI) powered drug solution platform, for the optimized discovery and early developm
Nov 09, 2023 08:00 am ET
Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts will present 19 scientific posters, both independently and collaboratively with clients, at Neuroscience 2023, the annual meeting of the Society for Neuroscience (SfN). The meeting, which brings together leading researchers from across the globe, will take place from November 11-15 in Washington, DC.
Nov 08, 2023 07:00 am ET
Charles River Laboratories Announces Third-Quarter 2023 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2023. For the quarter, revenue was $1.03 billion, an increase of 3.8% from $989.2 million in the third quarter of 2022.
Oct 19, 2023 08:00 am ET
Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new e-commerce ordering experience, offering clients real-time access into research model availability and pricing, as well as immediate order confirmation. The introduction of real-time ordering for Charles River’s Research Models & Services business digitizes a robust, industry-leading inventory, and provides a seamless online ordering experience.
Oct 16, 2023 08:30 am ET
Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2023 financial results on Wednesday, November 8th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 8th, at 8:30 a.m. ET.
Oct 16, 2023 08:00 am ET
Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ability to conduct preclinical cancer research using ITCC-P4’s well-characterized collection of 400 annotated pediatric cancer models. As a global partner, Charles River is offering clients access to this collection. These are critical models for re
Oct 11, 2023 08:00 am ET
Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that, while working toward previously announced environmental goals, the Company has achieved 90 percent renewable electricity globally. This progress is a result of virtual power purchase agreements (VPPAs) in North America (solar) and Europe (wind) that are anticipated to ultimately supply all facilities in those regions with 100 percent renewable electricity.
Sep 26, 2023 08:00 am ET
Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The platform has the capability to reduce LVV manufacturing timelines for gene and gene-modified cell therapies by up to 60 percent, translating to fewer than seven months compared to traditi
Sep 25, 2023 08:00 am ET
Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the opening of another RightSourceSM facility, and first in the United Kingdom, which will provide services to the Stevenage advanced therapies biocluster. RightSource is a
Sep 20, 2023 08:30 am ET
Charles River Laboratories to Host Virtual Investor Day
Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, September 21st, beginning at 8:30 a.m. ET.
Sep 14, 2023 08:00 am ET
Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences (“RS”), a data science-driven drug discovery firm, today announced a multi-program collaboration agreement to apply Logica™ across several previously undrugged targets in the RS po
Sep 11, 2023 08:00 am ET
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including:
Sep 09, 2023 07:00 pm ET
Lifshitz Law PLLC Announces Investigations of Luminar Technologies, Inc. (NASDAQ: LAZR), NextEra Energy, Inc. (NYSE: NEE), Cutera, Inc. (NASDAQ: CUTR), and Charles River Laboratories International, In
Luminar Technologies, Inc. (NASDAQ: LAZR) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading...
Sep 06, 2023 08:00 am ET
Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Meth
Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest SAS, a leader in the development and provision of next-generation sequencing (NGS) testing services for biopharmaceuticals, today announced the publication of the results of a seminal study in Vaccine. This unique study demonstrated that
Aug 24, 2023 08:00 am ET
Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
Charles River Laboratories International, Inc. (NYSE: CRL), today announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The rare disease organization will leverage Charles River’s market leading cell and gene contract development and manufacturing organization (CDMO) expertise in High Quality (HQ) plasmid DNA production, and Good Manufacturing Practice- (GMP) compliant plasmid DNA batches to manufacture HQ plasmid DNA for Fondazione Telethon’s lentivirus production that will be used in ex vivo cell and gene therapy.
Aug 22, 2023 09:00 pm ET
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL) on behalf of long-term stockholders following a class action complaint that was filed against Charles River on May 19, 2023 with a Class Period from May 5, 2020 to February 21, 2023. Our investigation concerns whether the board of directors of Charles River have breached their fiduciary duties to the company.
Aug 18, 2023 10:42 am ET
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors. If you have continuously...
Aug 09, 2023 01:52 pm ET
Lifshitz Law PLLC Announces Investigations of U.S. Bancorp (NYSE: USB), STEM, Inc. (NYSE: STEM), Charles River Laboratories International, Inc. (NYSE: CRL), and Virtu Financial, Inc. (NASDAQ: VIRT)
U.S. Bancorp (NYSE: USB) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company failed to disclose to investors: (i) U.S. Bank...
Aug 09, 2023 07:00 am ET
Charles River Laboratories Announces Second-Quarter 2023 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2023. For the quarter, revenue was $1.06 billion, an increase of 8.9% from $973.1 million in the second quarter of 2022.
Aug 08, 2023 12:07 pm ET
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors. If you have continuously...
Aug 01, 2023 08:00 am ET
Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
Charles River Laboratories International, Inc. (NYSE: CRL) announced the planned openings of Charles River Accelerator and Development Lab (CRADL®) locations in Seattle and Philadelphia, expanding contract vivarium space for the biopharmaceutical industry.
Jul 31, 2023 02:55 pm ET
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors. If you have continuously...
Jul 24, 2023 10:17 am ET
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors. If you have continuously...
Jul 19, 2023 12:14 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Jul 19, 2023 08:00 am ET
Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2023 financial results on Wednesday, August 9th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 9th, at 8:30 a.m. ET.
Jul 18, 2023 12:16 pm ET
DEADLINE ALERT for CRL and VIRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jul 18, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 5, 2020 and...
Jul 18, 2023 05:45 am ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
NEW YORK, July 18, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws.
Jul 17, 2023 01:49 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
NEW YORK, July 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jul 17, 2023 12:06 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
The Law Offices of Frank R. Cruz reminds investors of the upcoming July 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE:
Jul 17, 2023 10:21 am ET
CRL FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important July
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE: CRL) between May 5, 2020 and February 21, 2023, both dates inclusive (the “Class Period”), of...
Jul 17, 2023 09:20 am ET
Final Deadline for Charles River Laboratories International, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. (NYSE: CRL) Investors of July 18,
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Charles River Laboratories...
Jul 17, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, July 17, 2023 /PRNewswire/ -- Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders:
Jul 17, 2023 05:45 am ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Jul 16, 2023 09:30 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River, and Virtu and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stem, Inc. (NYSE: STEM), The Walt Disney Company (NYSE: DIS), Charles River...
Jul 16, 2023 10:35 am ET
Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., July 16, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL). The action charges Charles River with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Charles River's materially misleading statements and omissions to the public, Charles River's investors have suffered
Jul 15, 2023 01:00 pm ET
Jul 15, 2023 08:00 am ET
CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Op
NEW YORK, July 15, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) and reminds investors of the July 18, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Jul 14, 2023 08:00 pm ET
CHARLES RIVER 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Charle
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company’s securities between May 5, 2020 and February 21, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Massachusetts.
Jul 14, 2023 07:14 pm ET
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., July 14, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL).
Jul 14, 2023 11:13 am ET
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors. If you have...
Jul 14, 2023 05:45 am ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
NEW YORK, July 14, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws.
Jul 14, 2023 05:45 am ET
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, July 14, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL).
Jul 13, 2023 12:52 pm ET
DEADLINE ALERT for CRL, VIRT, CGC, CUTR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jul 13, 2023 12:47 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 – (NYSE: CRL)
The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc.. Shareholders who purchased shares of CRL during the class period listed are encouraged to contact the firm regarding possible lead...
Jul 13, 2023 12:26 pm ET
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL). To receive updates on the lawsuit, fill out the...
Jul 13, 2023 10:00 am ET
VTRS, VIRT & CRL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jul 13, 2023 05:45 am ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, July 13, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit.
Jul 12, 2023 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Charles River Laboratories International, Inc. - CRL
CEDARHURST, N.Y., July 12, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company's securities between May 5, 2020 and February 21, 2023, inclusive (the "Class Period"). Shareholders have until July 18, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Jul 12, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 - (NYSE: CRL)
NEW YORK, July 12, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc..
Jul 11, 2023 10:45 pm ET
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles...
Jul 11, 2023 07:06 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
NEW YORK, July 11, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jul 11, 2023 04:21 pm ET
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
LOS ANGELES, July 11, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL).
Jul 11, 2023 03:02 pm ET
Charles River Laboratories International, Inc.: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL) investors that the firm has initiated an investigation into possible securities violations and may file a class action on...
Jul 11, 2023 12:34 pm ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Jul 11, 2023 05:45 am ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
NEW YORK, July 11, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws.
Jul 11, 2023 01:45 am ET
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Clas
Bernstein Liebhard LLP: Do you, or did you, own shares of Charles River Laboratories, Inc. (NYSE: CRL)?Did you purchase your shares between May 5, 2020 and February 21, 2023, inclusive?Did you lose money in your investment in Charles River...
Jul 10, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Virtu, and Charles River and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stem, Inc. (NYSE: STEM), The Walt Disney Company (NYSE: DIS), Virtu Financial,...
Jul 10, 2023 03:53 pm ET
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
LOS ANGELES, July 10, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL).
Jul 10, 2023 12:25 pm ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws. Class Period: May 5, 2020...
Jul 10, 2023 12:07 pm ET
DEADLINE ALERT for VTRS, CRL, and VIRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jul 10, 2023 09:19 am ET
CRL INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on July 18, 2023 in Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories Inter
RADNOR, Pa., July 10, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL). The action charges Charles River with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Charles River's materially misleading statements and omissions to the public, Charles River's investors have suffered si
Jul 10, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, July 10, 2023 /PRNewswire/ -- Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders:
Jul 09, 2023 03:57 pm ET
CRL CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Charles River Laboratories International, Inc. (CRL)
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Charles River Laboratories...
Jul 09, 2023 03:10 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Jul 08, 2023 08:45 am ET
Jul 08, 2023 08:00 am ET
CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Op
NEW YORK, July 8, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) and reminds investors of the July 18, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Jul 07, 2023 10:50 pm ET
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action
NEW ORLEANS, July 7, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company's securities between May 5, 2020 and February 21, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Massachusetts.
Jul 07, 2023 12:56 pm ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Jul 07, 2023 12:27 pm ET
DEADLINE ALERT for CRL, VIRT, CGC, CUTR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jul 07, 2023 05:45 am ET
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, July 7, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL).
Jul 06, 2023 03:05 pm ET
Charles River Laboratories International, Inc.: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL) investors that the firm has initiated an investigation into possible securities violations and may file a class action on...
Jul 06, 2023 01:10 pm ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws. Class Period: May 5, 2020...
Jul 06, 2023 11:15 am ET
DEADLINE ALERT for VTRS, CRL, and VIRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jul 06, 2023 10:00 am ET
VTRS, VIRT & CRL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jul 06, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 - (NYSE: CRL)
NEW YORK, July 6, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc..
Jul 05, 2023 11:45 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $500,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE: CRL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 05, 2023 10:53 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Charles River Laboratories International, Inc. - CRL
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company’s securities between May 5, 2020 and February 21, 2023, inclusive...
Jul 05, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River, and Virtu and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stem, Inc. (NYSE: STEM), The Walt Disney Company (NYSE: DIS), Charles River...
Jul 05, 2023 12:30 pm ET
SHAREHOLDER CLASS ACTION REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories Inte
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jul 05, 2023 11:04 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Charles River Laboratories...
Jul 05, 2023 09:14 am ET
Kessler Topaz Meltzer & Check, LLP Reminds CRL Investors of July 18, 2023 Deadline in Securities Fraud Class Action Against Charles River Laboratories International, Inc. (CRL)
The law firm of Kessler Topaz Meltzer & Check, LLP (
Jul 05, 2023 07:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 04, 2023 10:26 pm ET
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories Inte
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL),...
Jul 03, 2023 11:45 pm ET
Jul 03, 2023 05:00 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
NEW YORK, July 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jul 03, 2023 12:44 pm ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Jul 03, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, July 3, 2023 /PRNewswire/ -- Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders:
Jul 02, 2023 11:30 pm ET
Jul 02, 2023 12:22 pm ET
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CRL
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE: CRL) between May 5, 2020 and February 21, 2023, both dates inclusive (the “Class Period”), of...
Jul 02, 2023 11:00 am ET
CRL Securities Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. (CRL) Investors of Upcoming Deadline in Securities Fraud Class Action L
RADNOR, Pa., July 2, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL). The action charges Charles River with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Charles River's materially misleading statements and omissions to the public, Charles River's investors have suffered sig
Jul 01, 2023 09:06 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Jul 01, 2023 02:11 pm ET
Jul 01, 2023 08:00 am ET
CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Op
NEW YORK, July 1, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) and reminds investors of the July 18, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Jun 30, 2023 10:50 pm ET
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories Inte
NEW ORLEANS, June 30, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company's securities between May 5, 2020 and February 21, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Massachusetts.
Jun 30, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Charles River, Virtu, Cutera, and Luminar and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Charles River Laboratories International, Inc. (NYSE: CRL), Virtu Financial,...
Jun 30, 2023 12:45 pm ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws. Class Period: May 5, 2020...
Jun 30, 2023 11:35 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 30, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 30, 2023 05:45 am ET
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK,, June 30, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL).
Jun 29, 2023 01:30 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 29, 2023 12:30 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 – (NYSE: CRL)
The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc.. Shareholders who purchased shares of CRL during the class period listed are encouraged to contact the firm regarding possible lead...
Jun 29, 2023 10:00 am ET
VTRS, VIRT & CRL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jun 29, 2023 09:33 am ET
DEADLINE ALERT for CRL, VIRT, CGC, CUTR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 29, 2023 05:45 am ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, June 29, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit.
Jun 28, 2023 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Charles River Laboratories International, Inc. - CRL
CEDARHURST, N.Y., June 28, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company's securities between May 5, 2020 and February 21, 2023, inclusive (the "Class Period"). Shareholders have until July 18, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Jun 28, 2023 07:15 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 28, 2023 01:06 pm ET
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL). To receive updates on the lawsuit, fill out the...
Jun 28, 2023 11:15 am ET
DEADLINE ALERT for VTRS, CRL, and VIRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 28, 2023 07:00 am ET
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Clas
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jun 28, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 - (NYSE: CRL)
NEW YORK, June 28, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc..
Jun 27, 2023 10:02 pm ET
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles...
Jun 27, 2023 12:52 pm ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Jun 27, 2023 12:17 pm ET
Charles River Laboratories International, Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. (CRL) Shareholders of Securities Fraud C
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Charles River Laboratories...
Jun 27, 2023 05:45 am ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
NEW YORK, June 27, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws.
Jun 26, 2023 06:00 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CRL
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE: CRL) between May 5, 2020 and February 21, 2023, both dates inclusive (the “Class Period”), of the...
Jun 26, 2023 01:02 pm ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws. Class Period: May 5, 2020...
Jun 26, 2023 12:17 pm ET
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
LOS ANGELES, June 26, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL).
Jun 26, 2023 10:00 am ET
JULY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 26, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, June 26, 2023 /PRNewswire/ -- Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders:
Jun 25, 2023 10:18 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Jun 25, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telephone and Data Systems, Stem, Disney, and Charles River and Encourages Investors to Contact the Fir
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telephone and Data Systems, Inc. (NYSE: TDS), Stem, Inc. (NYSE: STEM), The Walt...
Jun 24, 2023 02:30 pm ET
Jun 24, 2023 08:00 am ET
CHARLES RIVER SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Thei
NEW YORK, June 24, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) and reminds investors of the July 18, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Jun 23, 2023 11:07 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
NEW YORK, June 23, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jun 23, 2023 10:50 pm ET
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action
NEW ORLEANS, June 23, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company's securities between May 5, 2020 and February 21, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Massachusetts.
Jun 23, 2023 04:08 pm ET
Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Charles River Laboratories International, Inc. Investors in Securities Fraud Class Action Lawsuit
RADNOR, Pa., June 23, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL). The action charges Charles River with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Charles River's materially misleading statements and omissions to the public, Charles River's investors have suffered si
Jun 23, 2023 01:24 pm ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Jun 23, 2023 11:55 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 23, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 23, 2023 10:41 am ET
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
LOS ANGELES, June 23, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL).
Jun 23, 2023 05:45 am ET
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, June 23, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL).
Jun 22, 2023 12:59 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 – (NYSE: CRL)
The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc.. Shareholders who purchased shares of CRL during the class period listed are encouraged to contact the firm regarding possible lead...
Jun 22, 2023 12:21 pm ET
Lifshitz Law PLLC Announces Investigations of Canopy Growth Corporation (NASDAQ: CGC), STEM, Inc. (NYSE: STEM), Charles River Laboratories International, Inc. (NYSE: CRL), and Virtu Financial, Inc. (N
Canopy Growth Corporation (NASDAQ: CGC) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company failed to disclose to investors:...
Jun 22, 2023 12:19 pm ET
DEADLINE ALERT for VTRS, CRL, and VIRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 22, 2023 10:00 am ET
VTRS, VIRT & CRL Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jun 22, 2023 09:20 am ET
Charles River Laboratories International, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Charles River Laboratories International, Inc. Shareholders of Deadline in Securities Frau
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Charles River Laboratories...
Jun 22, 2023 06:00 am ET
Jun 22, 2023 05:45 am ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, June 22, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit.
Jun 21, 2023 10:51 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Charles River Laboratories International, Inc. - CRL
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Charles River Laboratories International, Inc. (NYSE: CRL), if they purchased the Company’s securities between May 5, 2020 and February 21, 2023, inclusive...
Jun 21, 2023 02:10 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Charles River Laboratories...
Jun 21, 2023 01:09 pm ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws. Class Period: May 5, 2020...
Jun 21, 2023 11:56 am ET
SHAREHOLDER DEADLINE ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against Charles River Laboratories International, Inc. (NYSE: CRL) Lead Pla
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is reminding investors that the deadline to move for lead plaintiff in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYS
Jun 21, 2023 11:34 am ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Charles River Laboratories Intl. Inc. (CRL), Cutera, Inc. (CUTR),
The law firm of Kirby McInerney LLP reminds investors that securities class action lawsuits have been filed on behalf of investors in securities of Charles River Laboratories Intl. Inc., Cutera, Inc., Luminar Technologies, Inc., and Tingo Group,...
Jun 21, 2023 10:30 am ET
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Clas
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jun 21, 2023 06:00 am ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 21, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 - (NYSE: CRL)
NEW YORK, June 21, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc..
Jun 20, 2023 10:50 pm ET
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories Inte
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL),...
Jun 20, 2023 05:15 pm ET
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
NEW YORK, June 20, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws.
Jun 20, 2023 01:11 pm ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 5, 2020 and...
Jun 20, 2023 06:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 19, 2023 09:30 pm ET
SHAREHOLDER ALERT: CRL CGC TPVG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / June 19, 2023 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Jun 19, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telephone and Data Systems, Stem, Disney, and Charles River and Encourages Investors to Contact the Fir
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telephone and Data Systems, Inc. (NYSE: TDS), Stem, Inc. (NYSE: STEM), The Walt...
Jun 19, 2023 01:31 pm ET
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories International, Inc. (NYSE: CRL) against certain of its officers and directors. If you have continuously...
Jun 19, 2023 12:53 pm ET
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of...
Jun 19, 2023 07:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 19, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
NEW YORK, June 19, 2023 /PRNewswire/ -- Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders:
Jun 18, 2023 08:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. ("Charles River" or "the Company") (NYSE:CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jun 17, 2023 09:56 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (NYSE: CRL). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
Jun 17, 2023 03:12 pm ET
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.